Panobinostat and venetoclax enhance the cytotoxicity of gemcitabine, busulfan, and melphalan in multiple myeloma cells
Benigno C. Valdez, Yang Li, David Murray, Yan Liu, Yago Nieto, Qaiser Bashir, Muzaffar H. Qazilbash, Börje S. Andersson
Topics & Concepts
PanobinostatGemcitabineCancer researchMelphalanCarboplatinPharmacologyPI3K/AKT/mTOR pathwayChemistryHistone deacetylase inhibitorHistone deacetylaseApoptosisBiologyMedicineTransplantationCancerInternal medicineChemotherapyCisplatinBiochemistryHistoneGeneHistone Deacetylase Inhibitors ResearchMultiple Myeloma Research and TreatmentsProtein Degradation and Inhibitors